Fortress Biotech, Inc. - FORM 10-K - EX-21.1 - March 31, 2021

Attached files

file filename
EX-32.2 - EX-32.2 - Fortress Biotech, Inc.fbio-20201231xex32d2.htm
EX-32.1 - EX-32.1 - Fortress Biotech, Inc.fbio-20201231xex32d1.htm
EX-31.2 - EX-31.2 - Fortress Biotech, Inc.fbio-20201231xex31d2.htm
EX-31.1 - EX-31.1 - Fortress Biotech, Inc.fbio-20201231xex31d1.htm
EX-23.1 - EX-23.1 - Fortress Biotech, Inc.fbio-20201231xex23d1.htm
EX-4.3 - EX-4.3 - Fortress Biotech, Inc.fbio-20201231xex4d3.htm
10-K - 10-K - Fortress Biotech, Inc.fbio-20201231x10k.htm

EXHIBIT 21.1

​

SUBSIDIARIES OF FORTRESS BIOTECH, INC.

​

Subsidiaries of Fortress Biotech, Inc. at December 31, 2020, with jurisdiction of incorporation or formation:

​

●Aevitas Therapeutics, Inc. (Delaware)
●Avenue Therapeutics, Inc. (Delaware)
●Baergic Bio, Inc. (Delaware)
●Caelum Biosciences, Inc. (Delaware), formerly FBIO Acquisition Corp. II
●Cellvation, Inc. (Delaware), formerly FBIO Acquisition Corp. I
●Checkpoint Therapeutics, Inc. (Delaware)
●Cyprium Therapeutics, Inc. (Delaware)
●Helocyte, Inc. (Delaware), formerly DiaVax Biosciences, Inc.
●Hepla Sciences, Inc. (Delaware), formerly FBIO Acquisition Corp. IV
●Journey Medical Corporation (Delaware)
●Mustang Bio, Inc. (Delaware)
●Oncogenuity, Inc. (Delaware), formerly FBIO Acquisition Corp. VI
●CB Securities Corporation (Massachusetts)
●Coronado SO Co. (Delaware)
●Escala Therapeutics, Inc., formerly Altamira Biosciences, Inc. (Delaware)
●FBIO Acquisition Corps. VI – XIV (Delaware)
●Fortress Biotech, China, Inc.
●Innmune Limited (United Kingdom)
●Tamid Bio, Inc. (Delaware)

Fortress Biotech, Inc. Reports